Pharmacokinetics and metabolism of the dipeptidyl peptidase IV inhibitor carmegliptin in rats, dogs, and monkeys

By Kuhlmann Olaf   Paehler Axel   Weick Idelette   Funk Christoph   Pantze Michael   Zell Manfred   Timm Uwe  

Xenobiotica, Vol. 40, Iss. 12, 2010-12 ,pp. : 840-852

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics and metabolism of [¹⁴C]anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in humans

By Furuta Shinji   Smart Clair   Hackett Andrew   Benning Rajdeep   Warrington Steve  

Xenobiotica, Vol. 43, Iss. 5, 2013-05 ,pp. : 432-442

Informa Healthcare

Access to resources Recommend Favorite

Improved Glucose Tolerance via Enhanced Glucose-Dependent Insulin Secretion in Dipeptidyl Peptidase IV-Deficient Fischer Rats

By Nagakura T.   Yasuda N.   Yamazaki K.   Ikuta H.   Yoshikawa S.   Asano O.   Tanaka I.  

Biochemical and Biophysical Research Communications, Vol. 284, Iss. 2, 2001-06 ,pp. : 501-506

Elsevier

Access to resources Recommend Favorite

Absorption, metabolism and excretion of [¹⁴C]gemigliptin, a novel dipeptidyl peptidase 4 inhibitor, in humans

By Kim Namtae   Patrick Lorna   Mair Stuart   Stevens Lloyd   Ford Gill   Birks Vicky   Lee Sung-Hack  

Xenobiotica, Vol. 44, Iss. 6, 2014-06 ,pp. : 522-530

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics and disposition of the novel dopamine agonist Z-7760 in rat after intravenous and oral administration

By Bollard M.   Caldwell J.   Taylor G. W.   Strolin-Benedetti M.   Semeraro C.  

Xenobiotica, Vol. 30, Iss. 10, 2000-10 ,pp. : 983-991

Informa Healthcare

Access to resources Recommend Favorite